Search fresh public links, source activity, and ready-to-use post angles for Precision Oncology.
Fresh curated links around Precision Oncology are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Novel approaches are urgently needed to improve availability of diagnostic assays, and recent efforts have shifted toward uncovering the biological pathways and molecular profiles...
Precision medicine has long promised a future in which a patient’s treatment is tailored to the molecular signatures written into their genome, transcriptome, epigenome, proteome a...
As oncology care grows personalized and home-based, support around treatment becomes as vital as treatment.
Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinatio...
RNA sequencing and AI help identify tumor-specific alternative splicing events that may reveal new precision oncology targets across solid tumors...
Predicting whether a cancer patient will respond to therapy has long been one of oncology’s most consequential gambles. For people with metastatic non-small cell lung cancer, the m...
“What was cancer, Grandpa?” These were words I hoped to hear from my grandchildren. As a practicing physician for over forty-five years, I wasn’t sure whether futuristic care would...
by Alejandra Paja-García, Rafael Romero-Becerra, Tero Aittokallio, Alberto López Pancreatic ductal adenocarcinoma (PDAC), with a 12% 5-year survival rate, is the most aggressive t...
Case study finds nearly 9 in 10 actionable cancer data points existed only in unstructured text invisible to standard EMR reporting; OncoLens Analytics helped the center lift on-ti...
From: oncodaily.com Brain metastases remain one of the most difficult complications of metastatic breast cancer. Approximately 30% of patients with metastatic disease will eventual...
Agentic AI is closing oncology's data gaps — from drug discovery to survivorship. See how AI agents in healthcare are reshaping cancer care today.
Mayo Clinic recently launched Precure with founding partner Thermo Fisher Scientific to help transform how the life sciences community understands the biological changes that occur...
The partnership builds on OpenEvidence's vision to develop “medical super-intelligence” based on agentic artificial intelligence, or a system of AI agents that can be subspecialist...
Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining...
Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.
Short-read RNA sequencing reporting the modifications that alter protein output is starting to make epitranscriptomics indispensable for patient selection in precision medicines. T...
The AI-powered virtual cell tailors treatments for breast cancer based on samples of each patient's tumor. The post A Digital Cell Predicts Which Drugs Will Be Most Effective in De...
Delve into Labiotech's October oncology roundup and find out about the news that caught our attention this last month. The post Oncology biotech news: key moves to watch in October...
AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale For patients facing uncertainty or fear around a cancer diagnosis, cancer biomarker...
A new review in Molecular Cancer maps how approved drugs from outside oncology could be repurposed, under a strict mechanism-first framework, to dismantle the four biological progr...
The Phase I dose escalation trial of ACESOT-1051 (NCT06260514) will accelerate its patient enrollment, with Aprea planning to more than triple its number of active clinical sites f...
RNA sequencing of urine cell-free RNA can detect bladder cancer, monitor residual disease and help predict whether patients may respond better to immunotherapy or chemotherapy...
by Jing Qian, Rania Bassiouni, Yuxin Jin, Seeta Rajpara, Monica Neuman, Varun U. Khetan, Bodour Salhia, David W. Craig, Joseph W. Carlson, Lynda D. Roman, John D. Carpten High-gra...
In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to understand patient tumor states and next-generation precli...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.